Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
213M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
44.4M
-
Shares change
-
-3.87M
-
Total reported value, excl. options
-
$444M
-
Value change
-
-$46.1M
-
Put/Call ratio
-
0.59
-
Number of buys
-
59
-
Number of sells
-
-69
-
Price
-
$10.00
Significant Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2021
168 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") as of Q3 2021.
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.4M shares
of 213M outstanding shares and own 20.84% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (6.48M shares), SUMMER ROAD LLC (5.62M shares), BlackRock Inc. (4.97M shares), VANGUARD GROUP INC (3.68M shares), DELTEC ASSET MANAGEMENT LLC (2.15M shares), STATE STREET CORP (1.67M shares), GEODE CAPITAL MANAGEMENT, LLC (1.31M shares), FMR LLC (1.14M shares), TWO SIGMA ADVISERS, LP (1.08M shares), and TWO SIGMA INVESTMENTS, LP (895K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.